Gilder Gagnon Howe & Co’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,678
Closed -$671K 266
2024
Q4
$671K Buy
+16,678
New +$671K 0.01% 227